Demographic Characteristics and Knowledge, Attitude, and Perception (KAP) Survey on COVID-19 Immunization among Pakistani Population: A Cross-Sectional Study

Authors

DOI:

https://doi.org/10.69547/TSFJB.020104

Keywords:

COVID-19, Demographic data, KAP survey, Vaccination

Abstract

The disastrous calamity of coronavirus disease, is accountable to wreak havoc on human health and economy, thus World Health Organization has declared it as a public health emergency of international concerns. This study is aimed to obtain the demographic and KAP (knowledge/attitude/perception) survey data, regarding coronavirus immunization. A questionnaire-based online cross-sectional survey was undertaken in Pakistan from May 2021 to June 2021. Data was analyzed using IBM SPSS v 21 and p<0.05 was considered significant. Among 265 participants, results of demographic data survey showed that 74% were females and 26% were males, including >80% respondents from Punjab, and 99.24% Muslims. p<0.05 was obtained for 20-29 years old students belonging to life sciences accountable for 65% overall as a significant result. In KAP survey, the obtained data showed sub-optimal results as: 72.45% participants were ready to get COVID-19 vaccine, 50.20% people got vaccinated due to health concerns, 34% knew about vaccine registration in Pakistan, 62% did not know about adverse effects while 16.60% reported about AstraZeneca side effects, 42% preferred testing before getting vaccine, 67% had no knowledge regarding preventive measures after vaccination, 26% found vaccines effective, 52% thought of getting COVID-19 after vaccination, 39% preferred second dose of vaccine (in case of allergic reaction after getting first dose), and 64% did not think about the tracker in the chip. Pakistani community has a positive attitude towards COVID-19 vaccines, but due to lack of knowledge, immediate awareness programs are mandatory to be conducted to complete mass vaccination.

References

Velavan TP, Meyer CG. The COVID‐19 epidemic. Tropical Medicine & International Health. 2020;25(3):278-280. doi:https://doi.org/10.1111/tmi.13383

Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Revista Clinica Espanola. 2020;221(1). doi:https://doi.org/10.1016/j.rceng.2020.03.001

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Raffaela Di Napoli. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls. Published online March 20, 2020.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. doi:https://doi.org/10.1016/s0140-6736(20)30183-5

Barati F, Pouresmaieli M, Ekrami E, Asghari S, Ziarani FR, Mamoudifard M. Potential Drugs and Remedies for the Treatment of COVID-19: a Critical Review. Biological Procedures Online. 2020;22(1). doi:https://doi.org/10.1186/ s12575-020-00129-1

Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. Journal of Clinical Medicine. 2020;9(6):1753. doi:https://doi.org/10.3390/jcm9061753

Saqlain M, Munir MM, Rehman SU, et al. Knowledge, attitude, practice and perceived barriers among healthcare workers regarding COVID-19: a cross-sectional survey from Pakistan. Journal of Hospital Infection. 2020;105(3):419-423. doi:https://doi.org/10.1016/j.jhin.2020.05.007

Green DR. SARS-CoV2 vaccines: Slow is fast. Science Advances. 2020;6(28):eabc7428. doi:https://doi.org/ 10.1126/sciadv.abc7428

Kashte S, Gulbake A, El-Amin III SF, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Human Cell. 2021;34(3). doi:https://doi.org/10.1007/s13577-021-00512-4

Belete TM. Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease. Infection and Drug Resistance. 2021;Volume 14:151-161. doi:https://doi.org/10.2147/idr.s288877

Wadman M. Public needs to prep for vaccine side effects. Science. 2020;370(6520):1022-1022. doi:https://doi.org/10.1126/science.370.6520.1022

Tayyeb M, Jehad A, Ahmad N, Abbas M, Akhtar N, Muhammad A. Contributing Factors of COVID-19’s Spread in Pakistan . Bull EnvPharmacol Life Sci. 2021;10(4):73-80.

Waris A, Atta UK, Ali M, Asmat A, Baset A. COVID-19 outbreak: current scenario of Pakistan. New Microbes and New Infections. 2020;35:100681. doi:https://doi.org/10.1016/j.nmni.2020.100681

Abbasi KR, Shahbaz M, Zhang J, Irfan M, Alvarado R. Analyze the environmental sustainability factors of China: The role of fossil fuel energy and renewable energy. Renewable Energy. 2022;187:390-402. doi:https://doi.org/10.1016/j.renene.2022.01.066

Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 Vaccine Challenges: What have we learned so far and what remains to be done? Health Policy. 2021;125(5). doi:https://doi.org/10.1016/j.healthpol.2021.03.013

Szmyd B, Bartoszek A, Karuga FF, Staniecka K, Błaszczyk M, Radek M. Medical Students and SARS-CoV-2 Vaccination: Attitude and Behaviors. Vaccines. 2021;9(2):128. doi: https://doi.org/10.3390/vaccines9020128

CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. Published February 11, 2020. https://www.cdc.gov/coronavirus/2019-ncov/science/science-and-research.html

COVID-19 Health Advisory Platform by Ministry of National Health Services Regulations and Coordination. https://www.covid.gov.pk/

Shukla VV, Shah RC. Vaccinations in Primary Care. The Indian Journal of Pediatrics. 2018;85(12):1118-1127. doi:https://doi.org/10.1007/s12098-017-2555-2

Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021;372:n699. doi:https://doi.org/10.1136/bmj.n699

Wise J. Covid-19: Rare immune response may cause clots after AstraZeneca vaccine, say researchers. BMJ. Published online April 12, 2021:n954. doi:https://doi.org/10.1136/bmj.n954

Rzymski P, Zeyland J, Poniedziałek B, Małecka I, Wysocki J. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Vaccines. 2021;9(4):382. doi:https://doi.org/10.3390/vaccines9040382

El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. Di Gennaro F, ed. PLOS ONE. 2021;16(4):e0250555. doi:https://doi.org/10.1371/journal.pone.0250555

Downloads

Published

2024-06-28

How to Cite

Aslam, L., Ashraf, M., & Mahmood, S. (2024). Demographic Characteristics and Knowledge, Attitude, and Perception (KAP) Survey on COVID-19 Immunization among Pakistani Population: A Cross-Sectional Study. TSF Journal of Biology, 2(1), 44–55. https://doi.org/10.69547/TSFJB.020104

Issue

Vol. 2 No. 1 (2024): Discovering Fresh Insights: Volume 2, Issue 1

Section

Research Articles

License

Copyright (c) 2024 Ms., Ms., Saher Mahmood

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Under the following terms:

  1. Attribution - You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  2. No additional restrictions - You may not apply legal terms ortechnological measures that legally restrict others from doing anything the license permits.